Pharma


 Faron Pharma's Candidate Earns FDA Fast Track

Faron Pharma's Candidate Earns FDA Fast Track

August 27, 2024 12:00 AM BST| By Team Kalkine Media

Faron Pharmaceuticals,(LSE:FARN),, a clinical-stage biopharmaceutical company, announced on Tuesday that its lead candidate, bexmarilimab, has received fast track designation from the US Food and Drug Administration (FDA). This designation applies to...

 Faron Pharmaceuticals to Expand Bexmarilimab Development Under New CMO

Faron Pharmaceuticals to Expand Bexmarilimab Development Under New CMO

August 06, 2024 11:25 AM BST| By Team Kalkine Media

On August 6, 2024, Faron Pharmaceuticals Ltd. (LSE: FARN), a clinical-stage biopharmaceutical firm focused on innovative cancer therapies, announced the appointment of Dr. Petri Bono as its new Chief Medical Officer (CMO). Dr. Bono will officially be...

 Destiny Pharma Shares Decline Despite Positive XF-73 MRSA Data

Destiny Pharma Shares Decline Despite Positive XF-73 MRSA Data

August 05, 2024 12:53 PM BST| By Team Kalkine Media

XF-73 Data Announced,Destiny Pharma PLC announced promising results for its lead drug, exeporfinium chloride, branded as XF-73, on Monday. The Brighton-based clinical-stage biotechnology company revealed data from a recent study indicating that XF-73...

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/uk/gallery/xlarge/shutterstock_2490200659_06_05_2026_15_45_57_645644.jpg

Can Depot Expansion Drive the Next Phase of Growth for Howden Joinery?

June 05, 2026 03:27 PM BST| By Ishan Mudgal

Howden Joinery Group plc is one of the United Kingdom's leading suppliers of fitted kitchens, joinery products, and hardware. The company operates a distinctive trade-onlyBusinessmodel, serving local builders and trade professionals through an extensive network of depots across the UK and selected European markets. …

Recent Articles






Investing Tips

Previous Next